Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 10
View:

• Male or female ≥ 10 years of age

• Diagnosis of HS by a dermatologist or practitioner experienced in making a diagnosis of HS

• Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study.

Locations
United States
California
University of California San Francisco
RECRUITING
San Francisco
Contact Information
Primary
Ashley Yates, MMS, PA-C
hsprogress@ucsf.edu
415-514-7655
Time Frame
Start Date: 2020-08-01
Estimated Completion Date: 2030-01-01
Participants
Target number of participants: 3000
Related Therapeutic Areas
Sponsors
Leads: University of California, San Francisco

This content was sourced from clinicaltrials.gov